Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.

about

Atypical antipsychotics for disruptive behaviour disorders in children and youths.Lurasidone for the treatment of irritability and anger in autism spectrum disorders.Executive Function Deficits in Seriously Ill Children-Emerging Challenges and Possibilities for Clinical Care.

P2860

Q38632745-54EDE104-8C83-4FDA-A809-7726545E7D14 Q38689883-684261CC-59FE-4A64-86A6-8ED5F1910A8F Q55028716-1FBDD786-369B-47A0-A0D9-F11D85991551

P2860

Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.

Item

http://www.wikidata.org/entity/Q38536898

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Metabolic side effects and pha ...... on antipsychotics in children.

@en

type

Item

label

Metabolic side effects and pha ...... on antipsychotics in children.

@en

prefLabel

Metabolic side effects and pha ...... on antipsychotics in children.

@en

P1476

Metabolic side effects and pha ...... on antipsychotics in children.

@en

P2860

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

Common variants near MC4R are associated with fat mass, weight and risk of obesity

Rising antipsychotic prescriptions for children and youth: cross-sectoral solutions for a multimodal problem

The endocannabinoid system: directing eating behavior and macronutrient metabolism

Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A)

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

Quality of medical care and excess mortality in older patients with mental disorders

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

P304

981-996

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.15.55

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Constadina Panagiotopoulos

Angela Devlin

P577

2015-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26107755

http://www.w3.org/2001/XMLSchema#string

Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.

about

P2860

P2860

Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698